Correlation Between Vertex Pharmaceuticals and VistaGen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and VistaGen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and VistaGen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and VistaGen Therapeutics, you can compare the effects of market volatilities on Vertex Pharmaceuticals and VistaGen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of VistaGen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and VistaGen Therapeutics.
Diversification Opportunities for Vertex Pharmaceuticals and VistaGen Therapeutics
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vertex and VistaGen is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and VistaGen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VistaGen Therapeutics and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with VistaGen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VistaGen Therapeutics has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and VistaGen Therapeutics go up and down completely randomly.
Pair Corralation between Vertex Pharmaceuticals and VistaGen Therapeutics
Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to generate 0.42 times more return on investment than VistaGen Therapeutics. However, Vertex Pharmaceuticals is 2.38 times less risky than VistaGen Therapeutics. It trades about 0.26 of its potential returns per unit of risk. VistaGen Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 39,935 in Vertex Pharmaceuticals on December 28, 2024 and sell it today you would earn a total of 9,961 from holding Vertex Pharmaceuticals or generate 24.94% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Vertex Pharmaceuticals vs. VistaGen Therapeutics
Performance |
Timeline |
Vertex Pharmaceuticals |
VistaGen Therapeutics |
Vertex Pharmaceuticals and VistaGen Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vertex Pharmaceuticals and VistaGen Therapeutics
The main advantage of trading using opposite Vertex Pharmaceuticals and VistaGen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, VistaGen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VistaGen Therapeutics will offset losses from the drop in VistaGen Therapeutics' long position.Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
VistaGen Therapeutics vs. Synlogic | VistaGen Therapeutics vs. AC Immune | VistaGen Therapeutics vs. Entera Bio | VistaGen Therapeutics vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |